NEW YORK (
) -- Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.
( TRMS) plummeted by 63 cents, or 19.8%, to $2.55 in the premarket session after
terminated its offer to acquire all outstanding shares of Trimeris. Arigene said it was unable to secure sufficient financing for the merger as of the expiration time of the tender offer. The 50-day average daily volume for Trimeris is 245,000 shares, according to the
slipped by 2 cents, or 2.1%, to 93 cents in the premarket session after the trucking company extended the deadline on a debt-for-equity offer for the fifth time, to Dec. 29. The swap is part of YRC Worldwide's efforts to stave off bankruptcy. The 50-day average daily volume for YRC Worldwide is 9.32 million.
surged by 9 cents, or 20.2%, to 54 cents in the premarket session after the company announced a study published in
The International Journal of Cancer
that describes its first novel dual mTOR Inhibitor, BN107, for the treatment of breast cancer. The 50-day average daily volume for Bionovo is 778,000 shares.
jumped by 31 cents, or 24.2%, to $1.59 in the premarket session after the company announced the sale of its Broadway Ticketing Division to privately held Key Brand Entertainment for $45 million in considerations. Upon completion of the transaction, which is expected in the first half of 2010, Hollywood Media will pay a one-time cash dividend of 60 cents a share. The 50-day average daily volume for Hollywood Media is 26,000.
United Community Banks
slumped by 20 cents, or 5.9%, to $3.21 in the premarket session after the company said it will temporarily suspend its common stock dividend. "
We believe the best way for every shareholder to benefit is to avoid further dilution and continue to position the company for future earnings growth and enhance our liquidity during this period of heightened economic and financial market volatility," the bank said. The 50-day average daily volume for United Community is 1.08 million shares.
At 7:43 a.m. EST
reported progress on the supplemental clinical trial for AppyScore, the first blood-based test designed to aid in the evaluation of patients suspected of having acute appendicitis. AspenBio has scheduled an interim analysis of the clinical trial data, and it has a meeting with the Food and Drug Administration scheduled for January. The 50-day average daily volume for AspenBio is 85,000 shares, according to the
. The stock closed Monday at $1.56.
raised revenue guidance for the fourth quarter to $17 million from the previous target range of $16 million to $16.7 million, above the Thomson Reuters consensus target of $16.5 million. "Strong bookings in the fourth quarter will contribute to the existing backlog and deferred revenues, providing us with high visibility into 2010," said CEO Dr. Moshe BenBassat. ClickSoftware now expects revenue to total $61 million for the 2009 fiscal year, compared with the average analyst target of $60.5 million. The three-month average daily volume for ClickSoftware is 437,000. Shares finished Monday's session at $6.93.
, which surged nearly 24% Monday on the company's $217-million merger agreement with private-equity firm Thomas Bravo, was downgraded by William Blair analysts to market perform from outperform Tuesday. The stock closed Monday's session at $5.47, above the $5.35-a-share price Thomas Bravo agreed to pay Amicas shareholders, although Amicas is allowed to solicit alternative proposals for 45 days beginning Dec. 24. The three-month average daily volume for Amicas is 271,000.
( SBIB) said late Monday it has terminated an agreement to buy
branches in Texas as they could not gain regulatory approval before the Dec. 31 deadline. The three-month average daily volume for Sterling is 1.1 million shares. Shares ended Monday's trading session at $5.25.
-- Written by Robert Holmes in Boston
Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store
Follow Robert Holmes on
and become a fan of TheStreet.com on